TissueScan, Lung Cancer cDNA Array II

SKU
HLRT502
TissueScan Lung Cancer Tissue qPCR Panel II (10) containing ten identical sets of 48 tissues covering four disease stages and normal tissues
  $2,500.00
In Stock*
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Lung Cancer cDNA Array II
Clinical Info
Diagnosis Category Lung Cancer
Tissue Lung
Shipping Ambient
Description TissueScan Lung Cancer Tissue qPCR Panel II (10) containing ten identical sets of 48 tissues covering four disease stages and normal tissues
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Downregulation of TRIB3 enhances the sensitivity of lung cancer cells to amino acid deprivation by suppressing AKT activation
Ahn, Jang, Kim et al
Am J Cancer Res (2024) 14 (4), 1622-1633 DOI: 10.62347/GLSY2976
AI Summary: OriGene's TissueScan lung cancer tissue qPCR panel (Lung Cancer cDNA array II #HLRT502) was used in this study to analyze TRIB3 mRNA expression across various lung cancer stages and normal tissues, contributing to the investigation of TRIB3’s role in lung cancer cell sensitivity to amino acid deprivation.
Snippet: … TissueScan lung cancer tissue qPCR panel (Lung Cancer cDNA array II #HLRT502) containing cDNAs from 48 tissues including all four lung cancer stages (stage I, n = 25;stage II, n = 6;stage III, n = 10;stage IV, n = 2) and normal controls (n = 5) was obtained from OriGene Technologies (Rockville, MD, USA). … The selective glutamine transporter ASCT2 inhibitor V-9302 (#HY-112683) was purchased from MedChemExpress (Monmouth Junction, NJ, USA)
Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions
Jin, Hong, Kim et al
Anticancer Res. (2019) 39 (12), 6723-6730 DOI: 10.21873/anticanres.13887
Cited by 38
AI Summary: OriGene contributed to this study by providing human lung cancer tissue samples (catalog numbers CP565586, CP565414, CP565564, and CP565534), which were used to analyze PSAT1 expression in various NSCLC subtypes.
Snippet: large cell carcinoma, #CP565586), lung cancer stage IIIA #6 (adenocarcinoma, #CP565414), lung cancer stage IIIA #7 (squamous carcinoma, #CP565564), and lung cancer stage IIIA #8 (large cell carcinoma, #CP565534) were purchased from OriGene Technologies
Induction of HSP27 and HSP70 by constitutive overexpression of Redd1 confers resistance of lung cancer cells to ionizing radiation
Jin, Hong, Kim et al
Oncol. Rep. (2019)
AI Summary: OriGene's TissueScan Lung Cancer Tissue qPCR panel (Lung Cancer cDNA array II #HLRT502) was used to analyze Redd1, HSP27, and HSP70 mRNA levels in lung cancer tissues, supporting the study's investigation of gene expression changes related to cancer progression and therapy resistance.
Snippet: Redd1, HSP27 and HSP70 mRNA levels in lung cancer were analyzed using a commercially available TissueScan Lung Cancer Tissue qPCR panel (Lung Cancer cDNA array II #HLRT502;Origene Technologies, Inc., Rockville, MD, USA)
Showing 1-3 of 3 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products